Advertisement Press Releases Archive - Page 5 of 231 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Pressreleases

  • Gerresheimer on Track to Another Strong Financial Year

    Gerresheimer, innovative provider of systems and solutions and global partner for the pharma, biotech, and cosmetics industries, made progress toward another strong financial year and a sustained improvement in profitability in the first nine months of 2023. Revenue grew organically (excluding exchange rate effects) by 12.6% year on year in the first nine months.

  • Gerresheimer Gx Elite Vials: Safely Putting Production in the Fast Lane

    Gerresheimer, an innovative system and solution provider and a global partner for the pharma and biotech industry, is launching Gx Elite, a product line of glass injection vials designed to maximise patient safety and production efficiency. Top quality and shatter resistance are the key priorities of the range. The advanced primary packaging solution is particularly suitable for sophisticated drugs such as biopharmaceuticals and cytostatics.

  • Gerresheimer at CPHI: Focus on High-Value Solutions and Sustainability

    Gerresheimer, an innovative system and solution provider and a global partner for the pharma and biotech industry, will present its extensive portfolio of containment solutions, drug delivery systems and digital solutions in areas such as therapy support at this year’s CPHI Barcelona. The company’s presence at the trade fair will focus on specialised primary packaging solutions for sensitive innovative drugs such as biopharmaceuticals, cell and gene therapy products — from COP injection vials for cryogenic temperatures starting at -80°C through to medication pumps.

  • Gerresheimer Joins the Science Based Targets Initiative

    Gerresheimer, innovative system and solution provider and global partner for the pharma and biotech industry, has joined the Science Based Targets initiative (SBTi). The organisation supports companies in using sound science to set and work toward targets for reducing greenhouse gas emissions. The SBTi will verify whether Gerresheimer’s own CO₂ reduction targets are in line with the Paris Agreement before transparently documenting the company’s progress on its platform.